Cranbury, NJ, United States of America

Uresh Shantilah Shah

This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uresh Shantilah Shah. Retrieved from https://idiyas.com/inventor/uresh-shantilah-shah

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Uresh Shantilah Shah: Innovator in Antidepressant Research

Introduction

Uresh Shantilah Shah, an inventive mind based in Cranbury, NJ, has made significant contributions to the field of pharmaceuticals, particularly in the development of antidepressants. With a focus on creating effective solutions for mental health, his research has paved the way for innovative treatments for various mood disorders.

Latest Patents

Uresh holds a notable patent titled "Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan." This patent is essential for the treatment of a wide range of conditions including major depressive disorder, childhood depression, and anxiety disorders. It also addresses issues related to post-traumatic stress disorder, attention deficit disorder, and eating disorders such as anorexia and bulimia. The compounds developed under this patent demonstrate therapeutic potential in alleviating symptoms of depression and other related illnesses.

Career Highlights

Uresh is currently affiliated with Wyeth, a pioneering pharmaceutical company known for its commitment to health innovations. His role has allowed him to collaborate on groundbreaking research that enhances the understanding and treatment of mental health conditions. Over the years, Uresh has been dedicated to advancing medical science through his inventive work and patents.

Collaborations

Throughout his career, Uresh has teamed up with distinguished colleagues such as Deborah Ann Evrard and Gary Paul Stack. Together, they have pushed the boundaries of research and development in the pharmaceutical industry, facilitating advances in therapeutic options for patients struggling with mental health issues.

Conclusion

Uresh Shantilah Shah's contributions to antidepressant innovation underscore the critical role of research and invention in the field of mental health. His patent not only reflects his ingenuity but also holds promise for improving the lives of individuals dealing with various psychological challenges. As he continues his work at Wyeth, the impact of his research is likely to resonate within the medical community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…